FDA and EMA Accept Regulatory Submission for Pfizer’s Ritlecitinib for Individuals 12 Years and Older with Alopecia Areata

Pfizer, Inc. announced that the FDA accepted for filing the New Drug Application for ritlecitinib for adults and adolescents 12 years of age and older with alopecia areata.